PCI Pharma Services welcomes Jim Neville as Operations Director at Tredegar, UK site PCI Pharma Services welcomes Jim Neville as Operations Director at Tredegar, UK site Neville takes responsibility for all manufacturing and engineering activities at the site Larry Grubb joins VanDeMark Chemical as VP of Global Sales & Business Development Larry Grubb joins VanDeMark Chemical as VP of Global Sales & Business Development Will spearhead market integration of VanDeMark and Framochem ClinTec appoints ex-AstraZeneca executive as Global Head of Clinical Operations ClinTec appoints ex-AstraZeneca executive as Global Head of Clinical Operations Alastair MacDonald joins the firm with almost 25 years of experience in clinical development Chronos Therapeutics strengthens management team with two appointments Chronos Therapeutics strengthens management team with two appointments Dr Fraser Murray and Dr Timothy Schulz-Utermoehl join the firm as Vice Presidents of Pre-Clinical Development Halocarbon hires H. Carl Walther as technical services manager Halocarbon hires H. Carl Walther as technical services manager 31-year veteran spent 18 years with Krytox performance lubricants PCI Pharma Services welcomes two new Business Development Executives PCI Pharma Services welcomes two new Business Development Executives To develop the outsourcing services provider's growing US business Parexel adds four executives to senior leadership team Parexel adds four executives to senior leadership team All have been with the firm for a number of years Cornelius makes a promotion Cornelius makes a promotion Darren Spiby moves up from Managing Director to Chief Executive Officer John C. Lechleiter to retire as CEO of Lilly John C. Lechleiter to retire as CEO of Lilly David A. Ricks will assume President and CEO roles on 1 January 2017 VBI Vaccines appoints Dr Francisco Diaz-Mitoma as Chief Medical Officer VBI Vaccines appoints Dr Francisco Diaz-Mitoma as Chief Medical Officer He will oversee clinical development initiatives at the firm ContraFect names Steven Gilman as Chief Executive Officer ContraFect names Steven Gilman as Chief Executive Officer The US firm is a developer of protein and anti-body therapeutics Ethiopia receives 14 million praziquantel tablets from Merck Ethiopia receives 14 million praziquantel tablets from Merck Will be used to treat the 23% of Ethiopians who are suffering from the worm disease schistosomiasis Certara appoints Nathan Teuscher to lead Phoenix software division Certara appoints Nathan Teuscher to lead Phoenix software division Phoenix is used to analyse the safety and efficacy of drugs under development PSL goes to Buckingham Palace to receive its Queen's Awards for Enterprise PSL goes to Buckingham Palace to receive its Queen's Awards for Enterprise The manufacturer of filter dryers, glove box and isolator containment systems for the pharmaceutical and biopharmaceutical industries was recognised for both Innovation and... Peakdale adds two new team members to extend its biological offering Peakdale adds two new team members to extend its biological offering Christopher Doe and Sascha Hartmann join the UK firm Adents hires Chuck Sailer as Serialisation Solutions Expert Adents hires Chuck Sailer as Serialisation Solutions Expert Sailer will apply his skills to Adents Pharma Suite, which uses standardised turnkey unit-level serialisation software